BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 36014859)

  • 1. Plasma Phospholipid Fatty Acids and Risk of Venous Thromboembolism: Mendelian Randomization Investigation.
    Yuan S; Li X; Morange PE; Bruzelius M; Larsson SC; On Behalf Of The Invent Consortium
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian Randomization Study Does Not Support a Bidirectional Link between Atherosclerosis and Venous Thromboembolism.
    Hu M; Gong Z; Yang Y
    J Atheroscler Thromb; 2023 Sep; 30(9):1265-1275. PubMed ID: 36529488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically predicted cortisol levels and risk of venous thromboembolism.
    Allara E; Lee WH; Burgess S; ; Larsson SC
    PLoS One; 2022; 17(8):e0272807. PubMed ID: 35984822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Cytokines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
    Hu T; Su P; Yang F; Ying J; Chen Y; Cui H
    Thromb Haemost; 2024 May; 124(5):471-481. PubMed ID: 38109907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies.
    Nazarzadeh M; Bidel Z; Mohseni H; Canoy D; Pinho-Gomes AC; Hassaine A; Dehghan A; Tregouet DA; Smith NL; Rahimi K;
    Cardiovasc Res; 2023 May; 119(3):835-842. PubMed ID: 36031541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Phospholipid Fatty Acids,
    Yuan S; Bäck M; Bruzelius M; Mason AM; Burgess S; Larsson S
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic variants related to plasma fatty acids with type 2 diabetes mellitus and glycaemic traits: a Mendelian randomisation study.
    Yuan S; Larsson SC
    Diabetologia; 2020 Jan; 63(1):116-123. PubMed ID: 31690987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.
    Roetker NS; Armasu SM; Pankow JS; Lutsey PL; Tang W; Rosenberg MA; Palmer TM; MacLehose RF; Heckbert SR; Cushman M; de Andrade M; Folsom AR
    J Thromb Haemost; 2017 Jul; 15(7):1334-1343. PubMed ID: 28445597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association and causal inference between lung function and venous thromboembolism.
    Zhang Q; Zhang X; Zhang J; Jiang M; Zhang Y; Zheng D; Wu L; Wang W; Wang B; Wang Y
    Respir Res; 2023 Jan; 24(1):36. PubMed ID: 36717884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and risk of venous thromboembolic diseases: A two-sample mendelian randomization study.
    Ma XS; Sun J; Geng R; Zhao Y; Xu WZ; Liu YH; Jiang YN; Li YQ
    Nutr Metab Cardiovasc Dis; 2023 May; 33(5):1087-1092. PubMed ID: 36958971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism.
    Ji L; Shu P
    Arthritis Res Ther; 2023 Jul; 25(1):122. PubMed ID: 37468959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation.
    Yuan S; Bruzelius M; Larsson SC
    J Thromb Thrombolysis; 2022 Jan; 53(1):43-50. PubMed ID: 34043151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study.
    Lv X; Gao X; Liu J; Deng Y; Nie Q; Fan X; Ye Z; Liu P; Wen J
    Front Immunol; 2022; 13():1042751. PubMed ID: 36582224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma phospholipid fatty acids, bone mineral density and fracture risk: Evidence from a Mendelian randomization study.
    Yuan S; Lemming EW; Michaëlsson K; Larsson SC
    Clin Nutr; 2020 Jul; 39(7):2180-2186. PubMed ID: 31564377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causality assessment of circulating Vitamin D level on venous thromboembolism: A Mendelian randomization study.
    Zhang X; Sun W; Li N; Jian X; Geng T; Wu L; Wang Y; Wang B; Zheng D
    Nutr Metab Cardiovasc Dis; 2023 Sep; 33(9):1800-1807. PubMed ID: 37414665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically predicted basal metabolic rate and venous thromboembolism risk: a Mendelian randomization study.
    Huang J; Xie Y
    Front Nutr; 2023; 10():1263804. PubMed ID: 38188880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis.
    Cornish N; Haycock P; Brenner H; Figueiredo JC; Galesloot TE; Grant RC; Johansson M; Mariosa D; McKay J; Pai R; Pellatt AJ; Samadder NJ; Shi J; Thibord F; Trégouët DA; Voegele C; Thirlwell C; Mumford A; Langdon R;
    Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38124529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty Acids and Frailty: A Mendelian Randomization Study.
    Tomata Y; Wang Y; Hägg S; Jylhävä J
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Causality between Diabetes and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
    Hu S; Tan JS; Hu MJ; Guo TT; Chen L; Hua L; Cao J
    Thromb Haemost; 2023 Sep; 123(9):913-919. PubMed ID: 36812941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.